lnu.sePublications
Planned maintenance
A system upgrade is planned for 10/12-2024, at 12:00-13:00. During this time DiVA will be unavailable.
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Activity in MCF-7 Estrogen-sensitive Breast Cancer Cells of Capsicodendrin from Cinnamosma fragrans
Linnaeus University, Faculty of Health and Life Sciences, Department of Chemistry and Biomedical Sciences. Ohio State Univ, USA.ORCID iD: 0000-0002-5005-0845
Ohio State Univ, USA.
Ohio State Univ, USA.
Ohio State Univ, USA.
2021 (English)In: Anticancer Research, ISSN 0250-7005, E-ISSN 1791-7530, Vol. 41, no 12, p. 5935-5944Article in journal (Refereed) Published
Sustainable development
SDG 3: Ensure healthy lives and promote well-being for all at all ages
Abstract [en]

Background/Aim: Effect of capsicodendrin on the NF-KB pathway was studied in MCF-7 cancer cells. Materials and Methods: The transcription factor assay was used to screen for NF-KB activity. The effect on IKK beta, ICAM-1, and caspase-7 were studied using western blot. Caspase-1 was studied using Promega Caspase-Glo (R) assay. Reactive oxygen species (ROS) were detected using the fluorescent probe DCFH-DA. The potentiometric dye JC-1 was used to assess mitochondrial membrane potential (Delta psi m) and the cell cycle was examined using a fluorescence-activated cell sorter. Results: NF-kappa B p65 inhibitory effect was IC50=8.6 mu M and cytotoxic activity was IC50=7.5 mu M. The upstream IKK and the downstream ICAM-1 were down-regulated. Sub G1-phase population increased to 81% after 12 h of treatment with capsicodendrin (10 mu M) and there was no loss of Delta psi M. Conclusion: Increased levels of intracellular ROS promoted activity of caspase-1 and induced cell death in MCF-7 cells. Capsicodendrin may be a future anticancer agent that prevents the progression of metastatic breast cancer.

Place, publisher, year, edition, pages
International Institute of Anticancer Research, 2021. Vol. 41, no 12, p. 5935-5944
Keywords [en]
Capsicodendrin, MCF-7, NF-kappa B, IKK beta, ICAM-1, ROS, caspase-7, caspase-1
National Category
Cancer and Oncology Pharmaceutical Sciences
Research subject
Biomedical Sciences, Pharmacology; Chemistry, Biochemistry
Identifiers
URN: urn:nbn:se:lnu:diva-108667DOI: 10.21873/anticanres.15412ISI: 000725492100007PubMedID: 34848447Scopus ID: 2-s2.0-85120482654OAI: oai:DiVA.org:lnu-108667DiVA, id: diva2:1621121
Available from: 2021-12-17 Created: 2021-12-17 Last updated: 2022-02-04Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Acuña, Ulyana Muñoz

Search in DiVA

By author/editor
Acuña, Ulyana Muñoz
By organisation
Department of Chemistry and Biomedical Sciences
In the same journal
Anticancer Research
Cancer and OncologyPharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 291 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf